DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, providing promising advancements across numerous healthcare and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA presents a safer, far more responsible option for therapeutic use, nota